These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1653578)

  • 1. [Effect of HMG-CoA reductase inhibitors on the erythrocyte membrane].
    Rabini RA; Antosiewicz J; Staffolani R; Polenta M; Testa I; Mazzanti L
    Boll Soc Ital Biol Sper; 1991 Feb; 67(2):129-35. PubMed ID: 1653578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.
    Rabini RA; Polenta M; Staffolani R; Tocchini M; Signore R; Testa I; Mazzanti L
    Exp Mol Pathol; 1993 Aug; 59(1):51-7. PubMed ID: 8262165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
    Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
    Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
    Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
    Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
    Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
    Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
    Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
    Coccia R; Spadaccio C; Foppoli C; Perluigi M; Covino E; Lusini M; Chello M
    Clin Ther; 2007 Aug; 29(8):1706-17. PubMed ID: 17919551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Bracaglia D; Cordova C
    Clin Ter; 1994 Jan; 144(1):3-9. PubMed ID: 8168349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.
    Calişkan S; Calişkan M; Kuralay F; Onvural B
    Res Exp Med (Berl); 2000 Feb; 199(4):189-94. PubMed ID: 10743676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
    Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ; Keller U; Oberhänsli A; Riesen WF
    Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.